PROTACs:当前和未来的潜力作为精准医学策略来打击癌症
Kailee A Rutherford1,2, Kirk J McManus1,2
1Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Molecular cancer therapeutics
|January 11, 2024
概括
针对蛋白质溶解的嵌合体 (PROTACs) 通过降解引起疾病的蛋白质,提供了一种新的精确医学方法. 这一策略增强了癌细胞的杀死,并为彻底改变癌症治疗提供了希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对蛋白质分解的嵌合体 (PROTACs) 是创新的异质双功能分子.
- 它们利用无素蛋白酶体系统进行向的蛋白质降解.
- PROTACs可以向以前无法治疗的蛋白质,包括coproteins.
研究的目的:
- 为了审查ubiquitin调节蛋白的正常功能.
- 描述PROTAC在改善广谱癌症治疗中的应用.
- 通过合成遗传方法探索 PROTACs 在利用癌症漏洞方面的潜力.
主要方法:
- 审查关于PROTACs和ubiquitin蛋白酶体系统的现有文献.
- 分析PROTACs针对特定蛋白质降解的机制.
- 讨论合成遗传策略与癌症治疗的PROTACs相结合.
主要成果:
- 通过劫持无处不在蛋白质酶系统,PROTACs有效地诱导向蛋白质降解.
- 它们提供了一种策略,可以准以前无法治疗的蛋白质,从而扩大治疗选择.
- 将PROTAC与合成遗传学结合起来,显示出新型癌症治疗的潜力.
结论:
- 在癌症治疗中,PROTACs代表了精密医学的重大进步.
- 进一步的研究和克服临床翻译挑战对于常规使用至关重要.
- 预计PROTACs将彻底改变癌症治疗,延迟疾病发病,并改善患者的治疗结果.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.3K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.6K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
01:30Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K